Issue 4, 2015
From the journal:

MedChemComm

Correction: Identification of tris-(phenylalkyl)amines as new selective h5-HT2B receptor antagonists

Shashikanth Ponnala,a   Nirav Kapadiaab  and  Wayne Wesley Harding*ab  

* Corresponding authors

a Chemistry Dept., Hunter College, CUNY, 695 Park Avenue, NY 10065, USA
E-mail: whardi@hunter.cuny.edu
Fax: +1 212 772 5332
Tel: +1 212 772 5359

b The Graduate Center, City University of New York, 365 5th Ave., NY 10016, USA

Abstract

Correction for ‘Identification of tris-(phenylalkyl)amines as new selective h5-HT2B receptor antagonists’ by Shashikanth Ponnala et al., Med. Chem. Commun., 2015, DOI: 10.1039/c4md00418c.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C5MD90005K
Article type
Correction
Submitted
12 Jan 2015
Accepted
12 Jan 2015
First published
23 Jan 2015
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2015,6, 732-732

Permissions

Request permissions

Correction: Identification of tris-(phenylalkyl)amines as new selective h5-HT2B receptor antagonists

S. Ponnala, N. Kapadia and W. W. Harding, Med. Chem. Commun., 2015, 6, 732 DOI: 10.1039/C5MD90005K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements